Listen to Associate Professor Cody Wenthur speak about the early stages of clinical trials using psilocybin and ketamine as treatments for challenging mental health conditions, as well as how the field is changing and growing.
psilocybin
Understanding the Anxiety-Reducing Effects of Psilocybin
School of Pharmacy Assistant Professor Cody Wenthur and his team are shedding new light on the role of stress in psychedelic drug treatment for mental health disorders.
Two First-in-Kind Clinical Trials Explore Psilocybin for Substance Misuse
Professor Paul Hutson and collaborators in the Transdisciplinary Center for Research in Psychoactive Substances study psilocybin for opioid and methamphetamine use disorders.
How Important is the ‘Psychedelic’ in Psychedelic Drug Therapies?
A new study led by School of Pharmacy researchers seeks to separate the psychedelic experience from the drugs’ therapeutic effects.